Market Size in 2024 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 7213.58 Million | USD 14,982.26 Million | 8.46% | 2023 |
The global smart syringe market size was worth around USD 7213.58 million in 2024 and is predicted to grow to around USD 14,982.26 million by 2032 with a compound annual growth rate (CAGR) of roughly 8.46% between 2024 and 2032.
Smart syringes are medical devices that are developed with a safety mechanism to prevent syringe reuse and facilitate safe injection practices. These syringes are engineered with advanced features to avoid the cases of needlestick injuries in people and prevent the transmission of various blood communicable diseases like hepatitis B, hepatitis C, human immunodeficiency virus, and several others. They offer a wide number of applications ranging from blood specimen collection to drug delivery.
Different types of smart syringes are available in the market like active safety syringes, passive safety syringes, and auto-disable syringes. The commonly used smart syringes in the healthcare sector all across the globe are the active safety syringes.
The growing prevalence of various target diseases all across the globe is one of the major factors driving the growth of the global smart syringe market vigorously. Moreover, the increasing prevalence of such diseases has significantly boosted the vaccination campaigns against the target disease in various parts of the world.
Also, the urgency to prevent the clinic-acquired infection will significantly propel the demand for smart syringes during the forecast period. The constantly growing geriatric population all across the globe is posing high demand for smart syringes.
However, due to the age-associated risk factor coupled with the unhealthy lifestyle, the elderly population all over the world is likely to suffer from several chronic diseases. However, all these factors are likely to escalate the growth of the global smart syringe market vigorously during the forecast period.
The global smart syringe market can be segmented into end-user, application, product, age-group, and region.
By end-user, the market can be segmented into hospitals and HMOs. The hospital segment accounts for the largest share in the global smart syringe market due to the growing demand for inpatient and outpatient hospital services.
By application, the market can be segmented into blood specimen collection, vaccination, and drug delivery. The drug-delivery segment holds the largest share in the global smart syringe market due to the growing prevalence of target diseases all across the globe. Also, the growing unmet requirements of vaccination across the developing and underdeveloped economies are also likely to boost the growth of the segment during the forecast period.
By product, the market can be segmented into passive safety syringes, active safety syringes, and auto-disable syringes. The auto-disable syringes segment dominates the global smart syringe market as these are the widely preferred devices for the administration of fluids and drugs because they are engineered with safety mechanisms that prevent its reuse and eliminate the possibility of disease transmission through needles.
By age group, the market can be segmented into adults and pediatrics. The adult segment holds hegemony over others due to the growing prevalence of several chronic and target diseases in the elderly population all across the globe.
Report Attributes | Report Details |
---|---|
Report Name | Smart Syringe Market Research Report |
Market Size in 2024 | USD 7213.58 Million |
Market Forecast in 2032 | USD 14,982.26 Million |
Growth Rate | CAGR of 8.46% |
Number of Pages | 215 |
Key Companies Covered | Baxter, Terumo Corporation, B. Braun Melsungen Ag, Cardinal Health, Becton, Dickinson and Company, Parker Hannifin Corp, Gerresheimer AG, Numedico Technologies Pty Ltd, AdvaCare Pharma, and Retractable Technologies, Inc. |
Segments Covered | By Product, By Age Group, By Application, By End-User and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America accounts for the largest share in the global smart syringe market due to the growing awareness regarding the various issues associated with traditional needles like needlestick injury cases. Moreover, the ongoing technological advancements in the medical sector in the region are likely to propel the growth of the regional market during the forecast period. However, the rapidly growing geriatric population in the region is another key factor boosting the growth of the regional market vigorously.
Asia Pacific is expected to witness huge growth during the forecast period due to the fast proliferation of the medical and healthcare sector in the region. Moreover, the increasing investments from the government authorities in order to strengthen the healthcare infrastructure in the region will further escalate the growth of the regional market during the forecast period.
The global smart syringe market is led by players like:
By Product
By Age Group
By Application
By End-User
Global Smart Syringe Market: Regional Segment Analysis
What Reports Provides
FrequentlyAsked Questions
Intelligent injectors may be equipped with mechanisms that quantify and exhibit the precise dosage of medication being administered. This aids in the prevention of incorrect dosages. Certain intelligent injectors are engineered to administer controlled or automated injections. Particularly advantageous in circumstances where accurate injection timing and velocity are critical.
Market expansion may be propelled by developments in intelligent hypodermic technology, including the incorporation of connectivity functionalities, enhanced safety mechanisms, and more precise dose measurement. Smart syringe innovations that improve their overall functionality and usability are expected to garner the interest of healthcare providers.
The global smart syringe market size was worth around USD 7213.58 million in 2024 and is predicted to grow to around USD 14,982.26 million by 2032.
The global smart syringe market with a compound annual growth rate (CAGR) of roughly 8.46% between 2024 and 2032.
The largest market share for smart syringes worldwide is located in North America, owing to the increasing recognition of the numerous problems associated with conventional needles, such as needlestick injuries. Furthermore, it is anticipated that the continuous technological progress within the medical industry in the area will stimulate the expansion of the regional market over the projected timeframe. Notwithstanding this, the region's geriatric population expansion at an alarming rate is an additional crucial factor propelling the regional market's robust expansion.
Some significant players in the global smart syringe market are Baxter, Terumo Corporation, B. Braun Melsungen Ag, Cardinal Health, Becton, Dickinson and Company, Parker Hannifin Corp, Gerresheimer AG, Numedico Technologies Pty Ltd, AdvaCare Pharma, and Retractable Technologies, Inc.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed